FDA update on brand drugs for September 3, 2008

[diana.papshev]

FDA update on brand drugs for September 3, 2008:

Valtrex (valacyclovir hydrochloride):
Expanded indication: for the treatment of cold sores (herpes labialis) in pediatric patients ≥12 years of age; for the treatment of chickenpox in immunocompetent pediatric patients 2 to <18 years of age

• Link to Prescribing information:

o Prescribing information

Stalevo (carbidopa; entacapone; levodopa):
New formulation: new strength tablets (75/18.75/200 and 125/31.25/200 mg)

• Link to FDA Letter:

o FDA Letter

• Link to Prescribing information:

o Prescribing information

Sources:
U.S. Food and Drug Administration. Drugs@FDA. Available at: Drugs@FDA